Active substances: Gabapentin
Tell all of your health care providers and lab workers that you take gabapentin tablets 600 mg and 800 mg.
Had that person never existed, would your life be the same today. A randomized trial of inhaled levodopa CVT-301 for motor fluctuations in Parkinson's disease.
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial. Long-term effects of rasagiline and the natural history of treated Parkinson's disease.
Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data. Journal of Medical Economics. JAMA Neurology.One of the many things that can go wrong in patient care is drug interactions, as they can result in patient suffering, costly and avoidable medical care, or even death.
Communicating with participants during the conduct of multi-center clinical trials. Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension.
The International Journal of Neuroscience.
Carbidopa levodopa enteral suspension. Expert Opinion on Pharmacotherapy. Clinical Neuropharmacology. NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.
The Lancet. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease nOH 306 B.
Who is helping whom? Manuscript support and transfer of value.
Annals of Neurology. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results. Initial choice of medication has little effect on short-term or long-term outcome for most patients with Parkinson's disease.